Physician

Jesus G Berdeja, M.D.

According to 2025 Medicare claims, Jesus Berdeja, M.D. (NPI: 1902842412) practices hematology/oncology in the Nashville-Davidson--Murfreesboro--Franklin, TN market, with the plurality of this provider's patient population coming from Davidson, TN. This provider's primary affiliated billing organization is TENNESSEE ONCOLOGY PLLC (NPI: 1811955917; TIN: 621647259) and primary practice location at 37203-1163.

Berdeja's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 287 traditional Medicare patients, billed 71,911 HCPCS/CPT codes, and received $2,939,861 in Medicare payments. The top billing code was 86334 (Immunologic analysis technique on serum (immunofixation)). Part D data shows 735 prescription claims across 89 beneficiaries totaling $7,237,624 in drug costs, led by Revlimid (Lenalidomide). Open Payments data shows 229 records totaling $2,238,850. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $914,086 to $2,939,861. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,323,894 to $7,237,624. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.5M$2.9M2015 Medicare payment: $914,086 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,140,864 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,012,161 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,344,808 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,094,956 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,521,284 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,681,324 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,195,945 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,523,409 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,939,861 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201529674,255$914,086
201627363,690$1,140,864
201728649,308$1,012,161
201831978,371$1,344,808
201930974,263$1,094,956
202031773,436$1,521,284
2021367106,190$1,681,324
202232373,655$1,195,945
202331971,054$1,523,409
202428771,911$2,939,861

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$3.6M$7.2M2015 Drug cost: $1,323,894 (USD; Tot_Drug_Cst)2016 Drug cost: $1,534,374 (USD; Tot_Drug_Cst)2017 Drug cost: $2,180,093 (USD; Tot_Drug_Cst)2018 Drug cost: $3,305,015 (USD; Tot_Drug_Cst)2019 Drug cost: $3,820,641 (USD; Tot_Drug_Cst)2020 Drug cost: $3,748,269 (USD; Tot_Drug_Cst)2021 Drug cost: $5,088,566 (USD; Tot_Drug_Cst)2022 Drug cost: $5,102,524 (USD; Tot_Drug_Cst)2023 Drug cost: $4,997,565 (USD; Tot_Drug_Cst)2024 Drug cost: $7,237,624 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015102724$1,323,894
201678771$1,534,374
201787815$2,180,093
201884706$3,305,015
2019110710$3,820,641
2020103740$3,748,269
2021113840$5,088,566
2022106807$5,102,524
202386603$4,997,565
202489735$7,237,624

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
86334Immunologic analysis technique on serum (immunofixation)117440$22
84165Protein measurement, serum117440$10
80053Blood test, comprehensive group of blood chemicals167742$10
36415Insertion of needle into vein for collection of blood sample179915$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count188984$7

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide2687,424$4,594,029
PomalystPomalidomide631,693$1,325,219
PromactaEltrombopag Olamine11300$257,841
JakafiRuxolitinib Phosphate15433$251,384
ImbruvicaIbrutinib12336$200,111

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.33$16,440E.R. Squibb & Sons, L.L.C.
Research PaymentsReported research-related payment or transfer-of-value amount.196$2,222,410SANOFI US SERVICES INC.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jesus G. Berdeja, M.D.?

Tedicare shows public-source Medicare data for Jesus G. Berdeja, M.D. (NPI 1902842412), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jesus G. Berdeja, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jesus G. Berdeja, M.D.?

Jesus G. Berdeja, M.D. is linked to TENNESSEE ONCOLOGY PLLC (billing NPI 1811955917) in the available physician profile data.

Does Jesus G. Berdeja, M.D. have Open Payments data?

Jesus G. Berdeja, M.D. has 229 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.